Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for OMER.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 -51.35M
March 31, 2026 -63.33M
December 31, 2025 -121.23M
September 30, 2025 -220.48M
June 30, 2025 -228.68M
March 31, 2025 -213.55M
December 31, 2024 -182.61M
September 30, 2024 -154.17M
June 30, 2024 -124.60M
March 31, 2024 -71.33M
December 31, 2023 -24.98M
September 30, 2023 -13.95M
June 30, 2023 20.51M
March 31, 2023 54.94M
December 31, 2022 85.68M
September 30, 2022 -46.31M
June 30, 2022 -32.70M
March 31, 2022 -4.925M
December 31, 2021 23.78M
September 30, 2021 -262.70M
June 30, 2021 -246.30M
March 31, 2021 -221.96M
December 31, 2020 -120.75M
September 30, 2020 -87.33M
June 30, 2020 -161.27M
Date Value
March 31, 2020 -131.86M
December 31, 2019 -109.02M
September 30, 2019 -139.92M
June 30, 2019 -130.27M
March 31, 2019 -121.02M
December 31, 2018 -100.16M
September 30, 2018 -89.00M
June 30, 2018 -56.30M
March 31, 2018 -29.22M
December 31, 2017 -2.814M
September 30, 2017 9.211M
June 30, 2017 -54.85M
March 31, 2017 -48.11M
December 31, 2016 -37.45M
September 30, 2016 -22.77M
June 30, 2016 -49.00M
March 31, 2016 -40.74M
December 31, 2015 -26.23M
September 30, 2015 -9.004M
June 30, 2015 7.932M
March 31, 2015 21.85M
December 31, 2014 -42.65M
September 30, 2014 -26.59M
June 30, 2014 -10.61M
March 31, 2014 5.212M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. 33.88B
Talphera, Inc. 14.41M
Hyperion DeFi, Inc. 101.93M
ANI Pharmaceuticals, Inc. 597.21M
Corcept Therapeutics, Inc. 705.78M

Shareholders Equity (Quarterly) Related Metrics